Pierre Fabre Laboratories Invests in MiYé

Pierre Fabre Laboratories has acquired a minority stake in MiYé, a French company specializing in skincare products and nutritional supplements aimed at improving hormonal balance and mental health in women. This capital increase will enable MiYé to accelerate its development by leveraging Pierre Fabre Laboratories' medical expertise and comprehensive knowledge of the pharmacy market. MiYé is a brand founded by women to help women live better and improve their quality of life during the period when they experience hormonal fluctuations from adolescence to menopause. Founded by Caroline de Blignières and Anna Oualid with the support of a scientific committee specialized in the endocrine system, MiYé chose to focus on the hormonal health market. The brand's innovative and disruptive approach addresses the underlying causes of hormonal imbalance symptoms, which are often taboo and misunderstood. MiYé currently offers a comprehensive product range of 13 products (5 dietary supplements and 8 dermo-cosmetics) focused on performance, naturalness, safety and ease of use. Pierre Fabre Laboratories, with roots dating back to 1962, is actively involved in women's health through a comprehensive portfolio of medical and dermo-cosmetic products, and through its investment subsidiary Pierre Fabre Invest, pursues a strategy of acquiring stakes in rapidly growing start-ups that complement its established dermo-cosmetic brands. Pierre Fabre Invest became the majority shareholder of Ladrôme Laboratoire (specialist in organic skincare and cosmetics) in 2021 and the sole shareholder of Même Cosmetics (specialist in healthy lifestyle treatments for cancer patients) in 2022. With this investment, it became the sole minority shareholder alongside MiYé's two founders. Source